INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 418m ago
HOUSE PTR17m ago
SEC 13F17m ago
ROBINHOOD CHAIN17m ago
SEC FORM 4/Option exerciseVerified data

Ewald Stephen P reported MEDP

General Counsel & Corp. Secy. · Medpace Holdings, Inc. · Common Stock

Side
M
Value
$486K
Shares
3,500
Price
$138.87
Executed
Apr 24, 2026
Disclosed
Apr 28, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Apr 24 executedApr 28, 2026 disclosed

MEDP · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
23/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+15 / 25

$486K reported value · 20.8% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · MEDP

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    36
    EP
    Ewald Stephen PGeneral Counsel & Corp. Secy.
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$859K
    1,245 sh
    		Oct 29, 2026Nov 2, 2026
    traded Oct 29, 2026
    		+4dSEC FORM 4

    Evidence

    46
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$10.87M
    16.1K sh
    		Oct 26, 2026Oct 28, 2026
    traded Oct 26, 2026
    		+2dSEC FORM 4

    Evidence

    12
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M$55K
    328 sh
    		Oct 26, 2026Oct 28, 2026
    traded Oct 26, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M—
    328 sh
    		Oct 26, 2026Oct 28, 2026
    traded Oct 26, 2026
    		+2dSEC FORM 4

    Evidence

    35
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$2.67M
    3,940 sh
    		Oct 27, 2026Oct 28, 2026
    traded Oct 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M—
    2,700 sh
    		Oct 21, 2026Oct 23, 2026
    traded Oct 21, 2026
    		+2dSEC FORM 4

    Evidence

    15
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M$450K
    2,700 sh
    		Oct 21, 2026Oct 23, 2026
    traded Oct 21, 2026
    		+2dSEC FORM 4

    Evidence

    21
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M—
    3,000 sh
    		Oct 12, 2026Oct 14, 2026
    traded Oct 12, 2026
    		+2dSEC FORM 4

    Evidence

    15
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M$500K
    3,000 sh
    		Oct 12, 2026Oct 14, 2026
    traded Oct 12, 2026
    		+2dSEC FORM 4

    Evidence

    15
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M$333K
    2,000 sh
    		Oct 7, 2026Oct 9, 2026
    traded Oct 7, 2026
    		+2dSEC FORM 4

    Evidence

    17
    BE
    Burwig Susan EExec. VP, Operations
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M—
    2,000 sh
    		Oct 7, 2026Oct 9, 2026
    traded Oct 7, 2026
    		+2dSEC FORM 4

    Evidence

    29
    TJ
    Troendle August J.Director, President & CEO, 10% Owner
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$10.11M
    16.1K sh
    		Sep 23, 2026Sep 25, 2026
    traded Sep 23, 2026
    		+2dSEC FORM 4

    Evidence

    33
    TJ
    Troendle August J.Director, President & CEO, 10% Owner
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$17.29M
    27.8K sh
    		Sep 24, 2026Sep 25, 2026
    traded Sep 24, 2026
    		+1dSEC FORM 4

    Evidence

    33
    TJ
    Troendle August J.Director, President & CEO, 10% Owner
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$13.64M
    21.9K sh
    		Sep 21, 2026Sep 23, 2026
    traded Sep 21, 2026
    		+2dSEC FORM 4

    Evidence

    33
    TJ
    Troendle August J.Director, President & CEO, 10% Owner
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$30.79M
    49.0K sh
    		Sep 22, 2026Sep 23, 2026
    traded Sep 22, 2026
    		+1dSEC FORM 4

    Evidence

    27
    KO
    Kraft Robert O.Director
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M$325K
    3,858 sh
    		Aug 26, 2026Aug 28, 2026
    traded Aug 26, 2026
    		+2dSEC FORM 4

    Evidence

    42
    KO
    Kraft Robert O.Director
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$2.38M
    3,858 sh
    		Aug 26, 2026Aug 28, 2026
    traded Aug 26, 2026
    		+2dSEC FORM 4

    Evidence

    9
    KO
    Kraft Robert O.Director
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M—
    3,858 sh
    		Aug 26, 2026Aug 28, 2026
    traded Aug 26, 2026
    		+2dSEC FORM 4

    Evidence

    27
    MP
    McCarthy Cornelius P. IIIDirector
    MEDPMedpace Holdings, Inc.
    Open-market sale
    		SELL$690K
    1,140 sh
    		Aug 11, 2026Aug 13, 2026
    traded Aug 11, 2026
    		+2dSEC FORM 4

    Evidence

    23
    MP
    McCarthy Cornelius P. IIIDirector
    MEDPMedpace Holdings, Inc.
    Option exercise
    		M$325K
    3,858 sh
    		Aug 7, 2026Aug 11, 2026
    traded Aug 7, 2026
    		+4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001677297-26-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Apr 24, 2026
    Published
    Apr 28, 2026
    Ingested by INSIDER
    Nov 5, 04:02 UTC
    Last re-read
    Nov 5, 04:02 UTC

    Extracted facts

    Filer
    Ewald Stephen P
    Role
    General Counsel & Corp. Secy.
    Transaction
    Option exerciseAs filed: “M”
    Asset
    Medpace Holdings, Inc.
    Ticker
    MEDP
    Shares
    3,500
    Price per share
    $138.87
    Value
    $486,045
    Execution date (reported)
    Apr 24, 2026
    Owned after transaction
    20.3K shares
    Days from execution to publication
    4

    Calculation

    Value = shares × reported price per share

    • Shares: 3,500
    • Price: $138.87

    = $486,045

    What this establishes

    Ewald Stephen P filed this Form 4 reporting a option exercise of MEDP on Apr 24, 2026. It became public on Apr 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    General Counsel & Corp. Secy.
    Ewald Stephen Pcik:0001677297
    Issuer
    Medpace Holdings, Inc.cik:0001668397

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.